Cordium Pharmaceuticals Pvt Ltd, a leading global pharma exporter in India, offers premium-quality Trastuzumab Biosimilar Injection (150mg & 440mg) for the effective treatment of HER2-positive cancers. With fast and secure worldwide delivery, we supply to major international markets including UAE, USA, UK, and South Africa.
🔬 What is Trastuzumab Biosimilar?
Trastuzumab is a monoclonal antibody that specifically targets the HER2 receptor, overexpressed in certain breast and gastric cancers. This biosimilar provides equivalent efficacy and safety compared to the original biologic, at a more affordable cost.
💊 Indications / Uses
- HER2-positive breast cancer (early-stage & metastatic)
- HER2-positive gastric (stomach) cancer
- Used alone or in combination with chemotherapy
📌 Dosage & Administration
- Administered via intravenous (IV) infusion under medical supervision
- Standard dosing:
- Loading dose: 8 mg/kg
- Maintenance dose: 6 mg/kg every 3 weeks
- Dosage may vary based on patient condition and physician recommendation
⚠️ Side Effects
Common side effects may include:
- Fever & chills
- Nausea and vomiting
- Fatigue
- Diarrhea
- Infusion-related reactions
Serious (rare) side effects:
- Cardiotoxicity (heart-related issues)
- Lung complications
- Severe allergic reactions
🚨 Precautions
- Regular cardiac monitoring is essential
- Not recommended during pregnancy or breastfeeding
- Inform your doctor about existing heart conditions
- Administer only under qualified healthcare supervision
🌍 Global Export & Fast Shipping
Cordium Pharmaceuticals ensures reliable international supply with express delivery to:
- UAE: Dubai, Abu Dhabi, Sharjah
- USA: New York City, Los Angeles, Washington
- UK: London, Manchester, Birmingham
- South Africa: Johannesburg, Cape Town, Durban
✅ Why Choose Cordium Pharmaceuticals?
- Trusted Indian pharma exporter
- Competitive pricing on oncology medicines
- Strict quality assurance & compliance
- Fast worldwide logistics support
📞 Contact Us Today for Bulk Orders & Enquiries:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
